430 related articles for article (PubMed ID: 30874733)
1. Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.
Mezza T; Moffa S; Ferraro PM; Quero G; Capece U; Carfì A; Cefalo CMA; Cinti F; Sorice GP; Impronta F; Mari A; Pontecorvi A; Alfieri S; Holst JJ; Giaccari A
J Clin Endocrinol Metab; 2019 Jul; 104(7):2685-2694. PubMed ID: 30874733
[TBL] [Abstract][Full Text] [Related]
2. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
3. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
[TBL] [Abstract][Full Text] [Related]
4. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
5. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
6. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
Christensen MB
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
[TBL] [Abstract][Full Text] [Related]
7. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
Mayer F; Gunawan AL; Tso P; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
[TBL] [Abstract][Full Text] [Related]
9. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
[TBL] [Abstract][Full Text] [Related]
10. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
11. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
12. Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
Sonne DP; Hare KJ; Martens P; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(4):G413-9. PubMed ID: 23275610
[TBL] [Abstract][Full Text] [Related]
13. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
Pathak V; Vasu S; Flatt PR; Irwin N
Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
[TBL] [Abstract][Full Text] [Related]
15. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
[TBL] [Abstract][Full Text] [Related]
16. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes.
Lee S; Yabe D; Nohtomi K; Takada M; Morita R; Seino Y; Hirano T
Endocr J; 2010; 57(2):119-26. PubMed ID: 19881250
[TBL] [Abstract][Full Text] [Related]
17. Novel extrapancreatic effects of incretin.
Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
[TBL] [Abstract][Full Text] [Related]
18. Removal of duodenum elicits GLP-1 secretion.
Muscogiuri G; Mezza T; Prioletta A; Sorice GP; Clemente G; Sarno G; Nuzzo G; Pontecorvi A; Holst JJ; Giaccari A
Diabetes Care; 2013 Jun; 36(6):1641-6. PubMed ID: 23393218
[TBL] [Abstract][Full Text] [Related]
19. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
20. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
